title: Immunization and treatment updates: 2016-2017 influenza season.
abstract: Influenza-associated infections cause significant morbidity and mortality worldwide, particularly among immunocompromised patients. Immunization is the primary mode of prevention of disease; however, efficacy in immunocompromised patients may be limited. Antiviral medications are important for treatment and prophylaxis of affected individuals. This article reviews treatment and prevention recommendations for the 2016-2017 influenza season in the Northern Hemisphere and Southern Hemisphere.
authors.affiliation: Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.
authors.forename: Annabelle
authors.identifier: http://orcid.org/0000-0001-7368-7403
authors.initials: A
authors.lastname: de St Maurice
authors.affiliation: Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.
authors.forename: Natasha
authors.initials: N
authors.lastname: Halasa
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007115:Immunization Schedule; D016867:Immunocompromised Host; D053118:Influenza A Virus, H1N1 Subtype; D053122:Influenza A Virus, H3N2 Subtype; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control*; D012621:Seasons; D066027:Transplant Recipients; D014611:Vaccination
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines